SECsense Logo

Tonix Pharmaceuticals 8-K Report: Key Updates & Insights for Investors

$TNXP
Form 8-K
Filed on: 2025-01-08
Source
Tonix Pharmaceuticals 8-K Report: Key Updates & Insights for Investors

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: January 8, 2025
  • Entity Name: Tonix Pharmaceuticals Holding Corp.
  • CIK Number: 0001430306
  • SEC Central Index Key: 001-36019
  1. Company Details:
  • Business Address: 26 Main Street, Chatham, NJ 07928
  • Contact Number: (862) 904-8182
  1. Ticker Symbol: TNXP
  • Exchange: NASDAQ
  1. Reporting Period:
  • As Of Date: January 8, 2025
  1. Financial Metrics:
  • Currency: USD
  • Units: Shares, USD per Share

This section indicates that Tonix Pharmaceuticals is reporting significant information regarding its common stock, as per the 8-K filing. The report is as of a specific date, suggesting it may contain material events or updates relevant to investors.